| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/17/2005 | EP1282418B1 Use of pyrazole derivatives for treating infertility |
| 08/17/2005 | EP1100878B8 Process for producing genetically modified cd34-negative adherently growing haematopoietic stem cells |
| 08/17/2005 | CN1656093A 3-substituted quinuclidines and their use |
| 08/17/2005 | CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 08/17/2005 | CN1656070A Melanocortin receptor ligands |
| 08/17/2005 | CN1655848A Use of new etonogestrel esters |
| 08/17/2005 | CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 08/17/2005 | CN1655796A Treatment of post-menopausal complaints in breast cancer patients which comprises tibolone and a SERM |
| 08/17/2005 | CN1655795A Progestagenic dosage units |
| 08/17/2005 | CN1655794A Norethindrone sustained release formulations and methods associated therewith |
| 08/17/2005 | CN1655786A Combination of a DPP IV inhibitor and a cardiovascular compound |
| 08/17/2005 | CN1655774A Bis-aromatic alkanols |
| 08/17/2005 | CN1654042A Method for preparing natural organic silk worm protein for improving insulin excretion in diabetes patients |
| 08/17/2005 | CN1215076C Heteroaromatic inhibitors of fructose 1, 6-bisphosphatase |
| 08/16/2005 | US6930123 Benz(f)indole compounds useful for Inflammatory Diseases |
| 08/16/2005 | US6930090 Methods of activating a receptor using amphiphilic drug-oligomer conjugates |
| 08/16/2005 | US6929817 Slowly digestible starch product |
| 08/11/2005 | WO2005073190A1 Selective estrogen receptor modulators |
| 08/11/2005 | WO2005072767A1 Agent for improving sugar metaboic function |
| 08/11/2005 | WO2004110983A8 New benzamides as pparϒ modulators |
| 08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 08/11/2005 | US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| 08/11/2005 | US20050176018 Increased nuclease resistance; gene expression inhibition |
| 08/11/2005 | DE10306992A1 Verfahren zur quantitativen Messung von Liganden in der Probe gelöster Bindungsproteine A method for quantitative measurement of ligand binding proteins in the sample dissolved |
| 08/10/2005 | EP1561751A1 Fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals |
| 08/10/2005 | EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 08/10/2005 | EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 08/10/2005 | EP1560575A1 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof |
| 08/10/2005 | EP1560573A2 Therapeutic agents and corresponding treatments |
| 08/10/2005 | EP1507514A4 Controlled release compositions of estradiol metabolites |
| 08/10/2005 | EP1471919B1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist |
| 08/10/2005 | EP1451166B1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 08/10/2005 | EP1399406B1 Novel estrogen receptor ligands and methods i |
| 08/10/2005 | CN1653075A C-aryl glucoside SGLT2 inhibitors and method |
| 08/10/2005 | CN1653068A Novel diazabicyclic biaryl derivatives |
| 08/10/2005 | CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 08/10/2005 | CN1653036A Amino acids with affinity for the alpha-2-delta-protein |
| 08/10/2005 | CN1652810A Immunosuppressant compounds, methods and uses related thereto |
| 08/10/2005 | CN1652799A Sulfatase inhibiting progestogen-only contraceptive regimens |
| 08/10/2005 | CN1652777A Combination of organic compounds |
| 08/10/2005 | CN1652768A 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replaceme |
| 08/10/2005 | CN1651087A Combination of organic compounds |
| 08/10/2005 | CN1214022C Vitamin D analogues |
| 08/10/2005 | CN1213980C Vitamin D analogues |
| 08/10/2005 | CN1213733C Method of preparing stable suspension of insoluble microparticles |
| 08/09/2005 | US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity |
| 08/09/2005 | US6927222 Compounds |
| 08/09/2005 | US6926898 Albumin fusion proteins |
| 08/04/2005 | US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/04/2005 | US20050171186 3-(1',2'-Dihydro-2'-thioxospiro[cyclohexane-1,3'-[3H]indol]-5'-yl)benzonitrile; 5'-(5-Cyano-1-methyl-1H-pyrrol-2-yl)spiro[cyclohexane-1,3'-[3H]indol]-2'-ylidenecyanamide; progesterone receptor agonist; mixture with estrone (estrogen); hormone replacement therapy, contraception; anticarcinogenic |
| 08/04/2005 | US20050171158 1-(sulfonylaminomethylcarbonyl)-4-cyclohexylpiperidine compounds such as N-[1-(R)-(4-chlorobenzyl)-2-(4-cyclohexyl-4-[1,2,4]triazol-1-ylmethyl-piperidin-1-yl)-2-oxo-ethyl]-methanesulfonamide; various diseases and disorders such as weight control, eating disorders |
| 08/04/2005 | US20050171128 Pyrrolo[2,3-d]pyrimidine compounds |
| 08/04/2005 | US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors |
| 08/04/2005 | US20050171104 Novel thyroid receptor ligands |
| 08/04/2005 | US20050171092 Chemical compounds |
| 08/04/2005 | US20050171087 high affinity agonists; high specificity; side effect reduction; endometriosis; hormone dependent cancers, fertility control; dibenzo[b,f]pyrido[1,2-d][1,4] oxazepin, dibenzo[b,f]pyrido[1,2-d][1,4]thiazepim, dibenzo[b,f]pyrido[1,2-d][1,4]diazepin and dibenzo[c,f]pyrido[1,2-a]azepine derivatives |
| 08/04/2005 | US20050171078 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |
| 08/04/2005 | US20050171075 Substitued 19-nor-cholestenes; antineoplastic agents, wound healing agents, antiinflammatory agents; autoimmune diseases, transplant rejection inhibition, hyperplasia, graft versus host disease; increased cell growth modulation and differentiation, low calcemic activity |
| 08/04/2005 | US20050171019 Administering an exendin modified with a polymer such as polyethylene glycol, gelatin and/or albumin to increase its biological half-life; treating hyperglucagonemia and diabetes, especially type II diabetes |
| 08/04/2005 | CA2553816A1 Di-steroidal prodrugs of ethinyl estradiol |
| 08/04/2005 | CA2552892A1 O-linked glycosylation of peptides |
| 08/03/2005 | EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 08/03/2005 | EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
| 08/03/2005 | EP1228059B1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 08/03/2005 | EP1175433B1 Androgen glycosides and androgenic activity thereof |
| 08/03/2005 | EP0851925B1 Human growth hormone variants |
| 08/03/2005 | EP0707596B1 Polymer-peptide conjugates |
| 08/03/2005 | CN1650024A Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 08/03/2005 | CN1650020A Means and methods for the production of adenovirus vectors |
| 08/03/2005 | CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/03/2005 | CN1649891A Improved synthesis of cyproterone acetate |
| 08/03/2005 | CN1649884A Novel azacyclic ethynyl derivatives |
| 08/03/2005 | CN1649879A Non-steroidal progesterone receptor modulators |
| 08/03/2005 | CN1649857A Hydroxamic acid derivatives |
| 08/03/2005 | CN1649855A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/03/2005 | CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF) |
| 08/03/2005 | CN1649843A Novel chalcone derivatives and uses thereof |
| 08/03/2005 | CN1649819A Novel thyroid receptor ligands |
| 08/03/2005 | CN1649595A Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 08/03/2005 | CN1649574A Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| 08/03/2005 | CN1649569A Controlled release dosage forms |
| 08/03/2005 | CN1649567A Composition having gelling properties for the prolonged delivery of bioactive substances |
| 08/03/2005 | CN1213036C Novel amide derivatives |
| 08/02/2005 | US6924297 Naphathalene derivatives which bind to the EP4 receptor |
| 08/02/2005 | US6924281 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 08/02/2005 | US6924280 Dipeptide derivatives |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6923988 Solid carrier includes a hydrophililc surfactant and a drug |
| 07/28/2005 | US20050165103 for enhancing the endogenous production of interleukin-10 (IL-10) and suppressing the production of interleukin-2 in mammalian cells or tissues; inhibiting the proliferation of stimulated peripheral mononuclear cells |
| 07/28/2005 | US20050165022 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/28/2005 | US20050165017 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050164995 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 07/28/2005 | US20050164989 Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative |